These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26087021)

  • 21. Structure-activity relationship, biological, and pharmacological characterization of the proline sulfonamide ACT-462206: a potent, brain-penetrant dual orexin 1/orexin 2 receptor antagonist.
    Boss C; Roch-Brisbare C; Steiner MA; Treiber A; Dietrich H; Jenck F; von Raumer M; Sifferlen T; Brotschi C; Heidmann B; Williams JT; Aissaoui H; Siegrist R; Gatfield J
    ChemMedChem; 2014 Nov; 9(11):2486-96. PubMed ID: 25147058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-molecule antagonists of the orexin receptors.
    Christopher JA
    Pharm Pat Anal; 2014; 3(6):625-38. PubMed ID: 25489915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia.
    Coleman PJ; Cox CD; Roecker AJ
    Curr Top Med Chem; 2011; 11(6):696-725. PubMed ID: 21261591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putting addiction to bed.
    Soares C
    Sci Am; 2010 Jul; 303(1):23-4. PubMed ID: 20583657
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for insomnia.
    Zisapel N
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):299-317. PubMed ID: 22681198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists.
    Stasi LP; Artusi R; Bovino C; Buzzi B; Canciani L; Caselli G; Colace F; Garofalo P; Giambuzzi S; Larger P; Letari O; Mandelli S; Perugini L; Pucci S; Salvi M; Toro P
    Bioorg Med Chem Lett; 2013 May; 23(9):2653-8. PubMed ID: 23535328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
    Xu TR; Yang Y; Ward R; Gao L; Liu Y
    Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on emerging drugs for insomnia.
    Sullivan S
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):295-8. PubMed ID: 22920041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements.
    Roecker AJ; Mercer SP; Bergman JM; Gilbert KF; Kuduk SD; Harrell CM; Garson SL; Fox SV; Gotter AL; Tannenbaum PL; Prueksaritanont T; Cabalu TD; Cui D; Lemaire W; Winrow CJ; Renger JJ; Coleman PJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4992-4999. PubMed ID: 25613676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats.
    Cataldi NI; Lux Lantos VA; Libertun C
    Regul Pept; 2014 Jan; 188():25-30. PubMed ID: 24333629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localization of orexin A and orexin type 2 receptor-positive cells in the placenta of dogs.
    Dall'Aglio C; Polisca A; Troisi A; Zelli R; Ceccarelli P
    Acta Histochem; 2014 Jun; 116(5):989-92. PubMed ID: 24745756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT(7) antagonists.
    Rudolph DA; Dvorak CA; Dvorak L; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2011 Jan; 21(1):42-4. PubMed ID: 21159507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orexin receptor antagonists--a patent review (2010 to August 2014).
    Boss C
    Expert Opin Ther Pat; 2014 Dec; 24(12):1367-81. PubMed ID: 25407283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The action of orexin B on passive avoidance learning. Involvement of neurotransmitters.
    Palotai M; Telegdy G; Ekwerike A; Jászberényi M
    Behav Brain Res; 2014 Oct; 272():1-7. PubMed ID: 24931796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach.
    Heidmann B; Gatfield J; Roch C; Treiber A; Tortoioli S; Brotschi C; Williams JT; Bolli MH; Abele S; Sifferlen T; Jenck F; Boss C
    ChemMedChem; 2016 Oct; 11(19):2132-2146. PubMed ID: 27390287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Almorexant, a dual orexin receptor antagonist for the treatment of insomnia.
    Neubauer DN
    Curr Opin Investig Drugs; 2010 Jan; 11(1):101-10. PubMed ID: 20047164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orexin receptor antagonists: a review of promising compounds patented since 2006.
    Coleman PJ; Renger JJ
    Expert Opin Ther Pat; 2010 Mar; 20(3):307-24. PubMed ID: 20180618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology.
    Gotter AL; Webber AL; Coleman PJ; Renger JJ; Winrow CJ
    Pharmacol Rev; 2012 Jul; 64(3):389-420. PubMed ID: 22759794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal.
    Sakurai T; Mieda M
    Trends Pharmacol Sci; 2011 Aug; 32(8):451-62. PubMed ID: 21565412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.